Detalhe da pesquisa
1.
Phase 1 study of lenzilumab, a recombinant anti-human GM-CSF antibody, for chronic myelomonocytic leukemia.
Blood
; 136(7): 909-913, 2020 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32294158
2.
Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.
Clin Ther
; 28(11): 1779-802, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17212999
3.
Effects of Trastuzumab Emtansine (T-DM1) on QT Interval and Safety of Pertuzumab Plus T-DM1 in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.
Clin Pharmacol Drug Dev
; 2(1): 11-24, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27121556
4.
Drug interaction potential of trastuzumab emtansine (T-DM1) combined with pertuzumab in patients with HER2-positive metastatic breast cancer.
Curr Drug Metab
; 13(7): 911-22, 2012 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22475266